We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 4 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 8 actions collected · 2 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 03. 19. | Oppenheimer | — | Initiate coverage | — → Outperform | — | Oppenheimer: Outperform |
| 2025. 06. 24. | Northland Capital Markets | — | Initiate coverage | — → Outperform | — | Northland Capital Markets: Outperform |
| 2024. 06. 24. | Noble Capital Markets | — | Initiate coverage | — → Outperform | — | Noble Capital Markets: Outperform |
| 2022. 02. 08. | Maxim Group | — | Maintain | — → Buy | — | Maxim Group: Buy |
| 2022. 02. 08. | Colliers Securities | — | Downgrade | Buy → Neutral | — | Colliers Securities: Buy → Neutral |
| 2019. 04. 18. | Maxim Group | — | Initiate coverage | — → Buy | — | Maxim Group: Buy |
| 2013. 02. 04. | Roth Capital | — | Downgrade | Buy → Neutral | — | Roth Capital: Buy → Neutral |
| 2012. 09. 24. | CJS Securities | — | Initiate coverage | — → Market Perform | — | CJS Securities: Market Perform |